Issue 2/2011

Genomic changes in salivary gland pleomorphic adenomas detected by comparative genomic hybridization (97 — 103)

H. GOUVERIS, C. G. LEHMANN, U. R. HEINRICH, W. J. MANN, J. BRIEGER

DOI: 10.4149/neo_2011_02_97

Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis (104 — 109)

L. JIA, X. F. YI, Z. B. ZHANG, Z. P. ZHUANG, J. LI, S. K. CHAMBERS, B. H. KONG, W. ZHENG

DOI: 10.4149/neo_2011_02_104

Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma (110 — 117)

Y. GUO, W. GUO, Z. CHEN, G. KUANG, Z. YANG, Z. DONG

DOI: 10.4149/neo_2011_02_110

Synergistic apoptotic effect of Arabinoxylan rice bran (MGN-3/Biobran) and Curcumin (Turmeric) on human multiple myeloma cell line U266 in vitro (118 — 123)

M. GHONEUM, S. GOLLAPUDI

DOI: 10.4149/neo_2011_02_118

Relationship of resistin levels with endometrial cancer risk (124 — 128)

M. HLAVNA, L. KOHUT, J. LIPKOVA, J. BIENERTOVA-VASKU, Z. DOSTALOVA, J. CHOVANEC, A. VASKU

DOI: 10.4149/neo_2011_02_124

Coagulation disorders in patients with locally advanced head and neck cancer – should they really be disregarded? (129 — 134)

B. JAGIELSKA, M. SYMONIDES, E. STACHURSKA, A. KAWECKI, E. KRASZEWSKA

DOI: 10.4149/neo_2011_02_129

Clinical implication of 18F-FDG PET/CT in carcinoma of unknown primary (135 — 139)

K. PAK, S. J. KIM, I. J. KIM, H. Y. NAM, B. S. KIM, K. KIM, Y. K. KIM

DOI: 10.4149/neo_2011_02_135

Quantification of ZAP-70 expression in chronic lymphocytic leukemia: T/B-cell ratio of mean fluorescence intensity provides stronger prognostic value than percentage of positive cells (140 — 145)

L. SMOLEJ, V. VROBLOVA, M. MOTYCKOVA, K. JANKOVICOVA, D. SCHMITZOVA, J. KREJSEK, J. MALY

DOI: 10.4149/neo_2011_02_140

Percutaneous US-guided needle biopsies of solid renal masses (146 — 152)

B. K. ARIBAŞ, K. ARDA, E. AKTAŞ, N. ÇILEDAĞ, F. YAKUT, G. ŞAHIN, Y. COŞAR, K. DOĞAN, G. KAYA

DOI: 10.4149/neo_2011_02_146

The Expression of Histone Demethylase JMJD1A in Renal Cell Carcinoma (153 — 157)

X. GUO, M. SHI, L. SUN, Y. WANG, Y. GUI, Z. CAI, X. DUAN

DOI: 10.4149/neo_2011_02_153

Silencing STAT3 may inhibit cell growth through regulating signaling pathway, telomerase, cell cycle, apoptosis and angiogenesis in hepatocellular carcinoma: potential uses for gene therapy (158 — 164)

X. H. WANG, B. R. LIU, B. QU, H. XING, S. L. GAO, J. M. YIN, X. F. WANG, Y. Q. CHENG

DOI: 10.4149/neo_2011_02_158

Trends in the kidney cancer incidence and mortality in the Slovak and Czech republics in 1980-2005 – in the context of an international comparison (165 — 171)

M. ONDRUSOVA, D. ONDRUS, J. MUZIK, L. HUNAKOVA, O. HES, J. KARABINOS, L. FRIEDOVA

DOI: 10.4149/neo_2011_02_165

Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer (172 — 178)

E. VRDOLJAK, M. BOBAN, T. OMRCEN, D. HREPIC, V. FRIDL-VIDAS, L. BOSKOVIC

DOI: 10.4149/neo_2011_02_172